Researchers have established the mechanism behind bone loss caused by chronic liver injury that might lead to the development of therapeutic drugs for hepatic bone disease.
A group of scientists has identified the role of progesterone in advanced prostate cancer and found a potential therapeutic target to suppress the generation of progesterone.